152
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Saliva cortisol and male depressive syndrome in a community study. The Sudurnesjamenn study

, , , &
Pages 145-152 | Accepted 14 Jun 2012, Published online: 02 Aug 2012

References

  • Krohg K, Hageman I, Jorgensen MB. Corticotropin-releasing factor (CRF) in stress and disease: A review of literature and treatment perspectives with special emphasis on psychiatric disorders. Nord J Psychiatry. 2008;62:8–16.
  • Christensen MV, Kessing LV. The hypothalamo-pituitary–adrenal axis in major affective disorder: A review. Nord J Psychiatry. 2001;55:359–63.
  • Herbert J. Cortisol and depression: Three questions for psychiatry. Psychol Med. 2012:1–21.
  • Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG. Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord. 1994;30:15–26.
  • Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, Jr., et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949–58.
  • Jorm AF. Sex and age differences in depression: A quantitative synthesis of published research. Aust N Z J Psychiatry. 1987;21:46–53.
  • Palsson SP, Ostling S, Skoog I. The incidence of first-onset depression in a population followed from the age of 70 to 85. Psychol Med. 2001;31:1159–68.
  • Hildebrandt MG, Stage KB, Kragh-Soerensen P. Gender and depression: A study of severity and symptomatology of depressive disorders (ICD-10) in general practice. Acta Psychiatr Scand. 2003;107:197–202.
  • Angst J, Gamma A, Gastpar M, Lepine JP, Mendlewicz J, Tylee A. Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci. 2002;252:201–9.
  • Moller-Leimkuhler AM. Barriers to help-seeking by men: A review of sociocultural and clinical literature with particular reference to depression. J Affect Disord. 2002;71:1–9.
  • Rutz W. Improvement of care for people suffering from depression: The need for comprehensive education. Int Clin Psychopharmacol. 1999;14 Suppl 3:S27–33.
  • Walter H, Gutierrez K, Ramskogler K, Hertling I, Dvorak A, Lesch OM. Gender-specific differences in alcoholism: Implications for treatment. Arch Womens Ment Health. 2003;6:253–8.
  • Kudielka BM, Hellhammer DH, Wust S. Why do we respond so differently?Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology. 2009;34:2–18.
  • Rutz W, Walinder J, Rhimer Z, Pestality P. [Male depression—Stress reaction combined with serotonin deficiency?].Lakartidningen. 1999;96:1177–8. Manlig depression—stressreaktion kombinerad med serotoninsvaghet?
  • van Praag H. Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis. Eur Psychiatry. 1996;11:57–67.
  • Walinder J, Rutzt W. Male depression and suicide. Int Clin Psychopharmacol. 2001;16 Suppl 2:S21–4.
  • van Praag HM. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression). Psychiatry Res. 1996;65:143–57.
  • Moller Leimkuhler AM, Heller J, Paulus NC. Subjective well-being and ‘male depression’ in male adolescents. J Affect Disord. 2007;98:65–72.
  • Nemeroff CB, Vale WW. The neurobiology of depression: Inroads to treatment and new drug discovery. J Clin Psychiatry. 2005;66 Suppl 7:5–13.
  • Holsboer F, Barden N. Antidepressants and hypothalamic–pituitary–adrenocortical regulation. Endocr Rev. 1996;17:187–205.
  • Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry. 1976;33:1051–8.
  • Peeters F, Nicolson NA, Berkhof J. Levels and variability of daily life cortisol secretion in major depression. Psychiatry Res. 2004;126:1–13.
  • Posener JA, DeBattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry. 2000;57:755–60.
  • Bremmer MA, Deeg DJ, Beekman AT, Penninx BW, Lips P, Hoogendijk WJ. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry. 2007;62:479–86.
  • Strickland PL, Deakin JF, Percival C, Dixon J, Gater RA, Goldberg DP. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry. 2002;180:168–73.
  • Vreeburg SA, Kruijtzer BP, van Pelt J, van Dyck R, DeRijk RH, Hoogendijk WJ, et al. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology. 2009;34:1109–20.
  • Doane LD, Franz CE, Prom-Wormley E, Eaves LJ, Mendoza SP, Hellhammer DH, et al. Negative emotionality, depressive symptoms and cortisol diurnal rhythms: Analysis of a community sample of middle-aged males. Hormones and behavior. 2011;60:202–9.
  • Hellhammer DH, Wust S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34:163–71.
  • Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus–pituitary–adrenal axis. Psychosom Med. 1999;61:154–62.
  • Leibenluft E. Gender differences in mood and anxiety disorders. From bench to bedside, 1st edition. Washington, DC: American Psychiatric Publishing, Inc; 1999 May 1999. 177 p.
  • Vaillancourt T, Duku E, Decatanzaro D, Macmillan H, Muir C, Schmidt LA. Variation in hypothalamic–pituitary–adrenal axis activity among bullied and non-bullied children. Aggress Behav. 2008;34:294–305.
  • Beck AT, Beamesderfer A. Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–69.
  • Zierau F, Bille A, Rutz W, Bech P. The Gotland Male Depression Scale: A validity study in patients with alcohol use disorder. Nord J Psychiatry. 2002;56:265–71.
  • Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998;83:1853–9.
  • Kirschbaum C, Hellhammer DH. Salivary cortisol in psychobiological research—An overview. Neuropsychobiology. 1989;22:150–69.
  • Skoog I, Nilsson L, Landahl S, Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr. 1993;5:33–48.
  • Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905–7.
  • Lecrubier Y. Widespread underrecognition and undertreatment of anxiety and mood disorders: Results from 3 European studies. J Clin Psychiatry. 2007;68 Suppl 2:36–41.
  • Van den Bergh BR, Van Calster B. Diurnal cortisol profiles and evening cortisol in post-pubertal adolescents scoring high on the Children's Depression Inventory. Psychoneuroendocrinology. 2009;34:791–4.
  • Stromberg R, Backlund LG, Lofvander M. A comparison between the Beck's Depression Inventory and the Gotland Male Depression Scale in detecting depression among men visiting a drop-in clinic in primary care. Nord J Psychiatry.
  • Bhattacharyya MR, Molloy GJ, Steptoe A. Depression is associated with flatter cortisol rhythms in patients with coronary artery disease. J Psychosom Res. 2008;65:107–13.
  • McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171–9.
  • Veen G, Giltay EJ, DeRijk RH, van Vliet IM, van Pelt J, Zitman FG. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders. Metabolism. 2009;58:821–7.
  • Mannie ZN, Harmer CJ, Cowen PJ. Increased waking salivary cortisol levels in young people at familial risk of depression. Am J Psychiatry. 2007;164:617–21.
  • Adam EK, Doane LD, Zinbarg RE, Mineka S, Craske MG, Griffith JW. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology. 2010;35:921–31.
  • Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: Methodological issues and significance. Stress. 2004;7:29–37.
  • Oldehinkel AJ, van den Berg MD, Flentge F, Bouhuys AL, ter Horst GJ, Ormel J. Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res. 2001;104:39–47.
  • Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry. 1998;172:527–32.
  • Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH. Hypothalamic–pituitary–adrenal axis function in patients with chronic depression. Psychol Med. 2002;32:1021–8.
  • Ehnvall A, Sjogren M, Zachrisson OC, Agren H. HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression. Eur Arch Psychiatry Clin Neurosci. 2004;254:349–55.
  • Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab. 2008;19:175–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.